Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
JAMP-Tobramycin
Synonyms :
Class :
Antibiotics & Aminoglycoside
Brand Name :
JAMP-Tobramycin
Synonyms :
Class :
Antibiotics & Aminoglycoside
measles, mumps, rubella, and varicella vaccine, live (Rx)
may diminish the therapeutic effect
measles mumps and rubella vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
smallpox (vaccinia) vaccine, live
may diminish the therapeutic effect
may diminish the therapeutic effect
lansoprazole, amoxicillin, and clarithromycin
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
amoxicillin and clavulanate potassium
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may enhance the serum concentration of Betalactamase Inhibitors
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may have an increased nephrotoxic effect when combined with colistimethate
lansoprazole, amoxicillin, and clarithromycin
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
there may be an increased risk of renal impairment
they increase the nephrotoxicity of other aminoglycosides
neomycin/polymyxin B/bacitracin topical
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may diminish the serum concentration of pencillins
neomycin/polymyxin B/gramicidin ophthalmicÂ
may increase the nephrotoxic effect of Polymyxin B
they increase the nephrotoxicity of other aminoglycosides
neomycin/polymyxin B/bacitracin topical
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
they increase the nephrotoxicity of other aminoglycosides
it increases the nephrotoxicity of aminoglycosides
it increases the nephrotoxicity of aminoglycosides
aminoglycosides increase the effect of neuromuscular blockage of mecamylamine
the adverse/toxic effects of aminoglycosides may be heightened by ataluren
the nephrotoxic effects of aminoglycosides may be enhanced by mannitol
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may diminish the metabolism of each other when combined
may enhance the renal tubular clearance for anionic drug competition
May increase the nephrotoxic effects of aminoglycoside antibiotics
May increase the nephrotoxic effects of aminoglycoside antibiotics
May increase the nephrotoxic effects of aminoglycoside antibiotics
May increase the nephrotoxic effects of aminoglycoside antibiotics
May increase the neuro-muscular-blocking effect of aminoglycoside antibiotics
May increase the nephrotoxicity of aminoglycoside antibiotics
May increase the nephrotoxicity of aminoglycoside antibiotics
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
may increase the serum concentration of Cardiac Glycosides
they increase the effect of hypocalcemia in bisphosphonate derivatives
they increase the effect of hypocalcemia in bisphosphonate derivatives
they increase the effect of hypocalcemia in bisphosphonate derivatives
they increase the effect of hypocalcemia in bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
may enhance the hypocalcemic effect of bisphosphonate derivatives
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
may enhance the hypocalcemic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may diminish the therapeutic effect
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
aminoglycosides increase the effect of hypocalcemia of bisphosphonate derivatives
may diminish the concentration of serum when combined with cardiac glycosides
may diminish the concentration of serum when combined with cardiac glycosides
may diminish the concentration of serum when combined with cardiac glycosides
may have an increased therapeutic effect when combined with neuromuscular-blocking agents
The harmful/toxic effect of aminoglycosides may be intensified by loop diuretics
The harmful/toxic effect of aminoglycosides may be intensified by loop diuretics
The harmful/toxic effect of aminoglycosides may be intensified by loop diuretics
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
the excretion rate of tobramycin, when decreased by pralidoxime, results in increased serum level
both tobramycin and acyclovir cause increased ototoxicity and/or nephrotoxicity
may increase the nephrotoxic effect of cephalosporins
neomycin/polymyxin B/bacitracin topical
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Antibiotics
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
may increase the anticoagulant effect of Cephalosporins
ioxilan may decrease the excretion rate of tobramycin, potentially resulting in a higher serum level
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of Aminoglycosides
penicillins may decrease the serum concentration of aminoglycosides.
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may decrease the excretion of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may enhance the nephrotoxic effect of aminoglycosides
may decrease the excretion of non-steroidal anti-inflammatory drugs
loop diuretics may increase the risk of adverse effect of aminoglycosides
loop diuretics may increase the risk of adverse effect of aminoglycosides
loop diuretics may increase the risk of adverse effect of aminoglycosides
may increase the nephrotoxic effect of aminoglycosides
may increase the nephrotoxic effect of aminoglycosides
may increase the nephrotoxic effect of aminoglycosides
may increase the nephrotoxic effect of cephalosporins
may increase the anticoagulant effect of cephalosporins
may decrease the excretion of nonsteroidal anti-inflammatory agents
may have an increased neuromuscular-blocking effect when combined with botulinum toxin-containing products
may enhance the nephrotoxicity of aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may increase the nephrotoxic effect of Amphotericin B
may decrease the therapeutic effect of antibiotics
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cyclosporine
Penicillins: they may diminish the serum concentration of aminoglycosides
amoxicillin and clavulanate potassium
Penicillins: they may diminish the serum concentration of aminoglycosides
Penicillins: they may diminish the serum concentration of aminoglycosides
Penicillins: they may diminish the serum concentration of aminoglycosides
Penicillins: they may diminish the serum concentration of aminoglycosides
it increases the nephrotoxicity of aminoglycosides
it increases the nephrotoxicity of aminoglycosides
it increases the effect of neuromuscular blockage of aminoglycosides
they increase the effect of nephrotoxicity of aminoglycosides
they increase the effect of nephrotoxicity of aminoglycosides
they increase the effect of nephrotoxicity of aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may diminish the concentration of serum when combined with aminoglycosides
may diminish the concentration of serum when combined with aminoglycosides
may diminish the serum concentration when combined with aminoglycosides
may diminish the serum concentration when combined with aminoglycosides
may diminish the excretion when combined with aminoglycosides
meningococcal A C Y and W-135 diphtheria conjugate vaccine
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
may increase the nephrotoxic effect of cephalosporins
aminoglycosides may augment the ototoxic effect of carboplatin, particularly with higher doses of carboplatin
may diminish the excretion when combined with aminoglycosides
may enhance the renal tubular clearance for anionic drug competition
Frequency defined:Â Â
1% to 10%Â
NeurotoxicityÂ
NephrotoxicityÂ
Auditory ototoxicity Â
<1%:Â
ArthralgiaÂ
DrowsinessÂ
Drug feverÂ
HeadacheÂ
Skin rashÂ
TremorÂ
VomitingÂ
WeaknessÂ
Â
Pregnancy consideration: Tobramycin (systemic) can cross the placenta and cause fetal harm to a pregnant woman.Â
Lactation: tobramycin can be present in breast milk, not recommended for lactating females.Â
Pregnancy category:Â
Patient information leafletÂ
Generic Name: TobramycinÂ
Pronounced: To-bra-may-sinÂ
Â
Why do we use tobramycin?Â
Tobramycin is an aminoglycoside antibiotic. Tobramycin (systemic) is used to treat several bacterial infections such as cystic fibrosis, urinary tract infection, sepsis pneumonia, and other serious infections. Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
